Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Merck Sharp & Dohme LLC recalls Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Presence of particulate matter: potential presence of metal particulates in the product.
Products
  • Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension
Where it was sold

Nationwide in the USA

Nationwide

Units affected
845 kits
About this recall
Noxafil Powdermix (posaconazole) for Delayed-Release Oral Suspension, 300 mg, 8 packets per carton, Rx Only, Manufactured for: Merck Sharp & Doohme LLC, Rahway, NJ 07056 USA, Manufactured by: N.V. Organon, 5349 AB Oss, The Netherlands, a subsidiary of Organon & Co., Jersey City, NJ 07302, USA NDC 0085-2224-02.